The Use of Psychostimulants in Pervasive Developmental Disorders

Overview

Journal Psychiatr Q

Specialty Psychiatry

Date 2005 Aug 6

PMID 16080422

Citations 1

Authors

Patricia Karen Abanilla

Greg A Hannahs

Robyn Wechsler

Raul R Silva

Affiliations

Soon will be listed here.

Abstract

Many children with Pervasive Developmental Disorders (PDD) display problematic behaviors similar to those seen in children with Attention Deficit Hyperactivity Disorder (ADHD). This paper will look at the controversy concerning diagnosing comorbid ADHD in children who meet criteria for PDD and review the existing literature examining the efficacy of stimulants in these particular set of behaviors or symptom clusters (hyperactivity, impulsivity and inattention). The potential drawbacks of using stimulants in a population of children and adolescents who exhibit symptoms of PDD and ADHD will be discussed. Finally, this review will also attempt to define potential areas of future research to examine the utility of the psychostimulants in children and adolescents with PDD and symptoms of ADHD.

Citing Articles

The effect of stimulants on irritability in autism comorbid with ADHD: a systematic review.

Ghanizadeh A, Molla M, Olango G Neuropsychiatr Dis Treat. 2019; 15:1547-1555.

PMID: 31239689 PMC: 6559223. DOI: 10.2147/NDT.S194022.

References

Campbell M, Small A, Collins P, Friedman E, David R, Genieser N . Levodopa and levoamphetamine: a crossover study in young schizophrenic children. Curr Ther Res Clin Exp. 1976; 19(1):70-86. View

Pearson D, Santos C, Casat C, Lane D, Jerger S, Roache J . Treatment effects of methylphenidate on cognitive functioning in children with mental retardation and ADHD. J Am Acad Child Adolesc Psychiatry. 2004; 43(6):677-85. DOI: 10.1097/01.chi.0000124461.81324.13. View

Birmaher B, Quintana H, Greenhill L . Methylphenidate treatment of hyperactive autistic children. J Am Acad Child Adolesc Psychiatry. 1988; 27(2):248-51. DOI: 10.1097/00004583-198803000-00020. View

Handen B, Breaux A, Gosling A, Ploof D, Feldman H . Efficacy of methylphenidate among mentally retarded children with attention deficit hyperactivity disorder. Pediatrics. 1990; 86(6):922-30. View

Luteijn E, Serra M, Jackson S, Steenhuis M, Althaus M, Volkmar F . How unspecified are disorders of children with a pervasive developmental disorder not otherwise specified? A study of social problems in children with PDD-NOS and ADHD. Eur Child Adolesc Psychiatry. 2000; 9(3):168-79. DOI: 10.1007/s007870070040. View

Stigler K, Desmond L, Posey D, Wiegand R, McDougle C . A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. J Child Adolesc Psychopharmacol. 2004; 14(1):49-56. DOI: 10.1089/104454604773840481. View

Jacobson J . Problem behavior and psychiatric impairment within a developmentally disabled population I: behavior frequency. Appl Res Ment Retard. 1982; 3(2):121-39. DOI: 10.1016/0270-3092(82)90002-9. View

Geller B, Guttmacher L, Bleeg M . Coexistence of childhood onset pervasive developmental disorder and attention deficit disorder with hyperactivity. Am J Psychiatry. 1981; 138(3):388-9. DOI: 10.1176/ajp.138.3.388. View

Strayhorn Jr J, Rapp N, Donina W, Strain P . Randomized trial of methylphenidate for an autistic child. J Am Acad Child Adolesc Psychiatry. 1988; 27(2):244-7. DOI: 10.1097/00004583-198803000-00019. View

10.

Roeyers H, Keymeulen H, Buysse A . Differentiating attention-deficit/hyperactivity disorder from pervasive developmental disorder not otherwise specified. J Learn Disabil. 1998; 31(6):565-71. DOI: 10.1177/002221949803100606. View

11.

Campbell M, Fish B, David R, Shapiro T, Collins P, Koh C . Response to triiodothyronine and dextroamphetamine: a study of preschool schizophrenic children. J Autism Child Schizophr. 1972; 2(4):343-58. DOI: 10.1007/BF01538168. View

12.

Spencer T, Biederman J, Wilens T, Harding M, ODonnell D, Griffin S . Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry. 1996; 35(4):409-32. DOI: 10.1097/00004583-199604000-00008. View

13.

Hoshino Y, KUMASHIRO H, Kaneko M, Takahashi Y . The effects of methylphenidate on early infantile autism and its relation to serum serotonin levels. Folia Psychiatr Neurol Jpn. 1977; 31(4):605-14. DOI: 10.1111/j.1440-1819.1977.tb00131.x. View

14.

Pearson D, Lane D, Santos C, Casat C, Jerger S, Loveland K . Effects of methylphenidate treatment in children with mental retardation and ADHD: individual variation in medication response. J Am Acad Child Adolesc Psychiatry. 2004; 43(6):686-98. DOI: 10.1097/01.chi.0000120024.14101.96. View

15.

Ghaziuddin M, Tsai L, Alessi N . ADHD and PDD. J Am Acad Child Adolesc Psychiatry. 1992; 31(3):567. DOI: 10.1097/00004583-199205000-00035. View

16.

Handen B, Johnson C, Lubetsky M . Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. J Autism Dev Disord. 2000; 30(3):245-55. DOI: 10.1023/a:1005548619694. View

17.

Pearson D, Santos C, Roache J, Casat C, Loveland K, Lachar D . Treatment effects of methylphenidate on behavioral adjustment in children with mental retardation and ADHD. J Am Acad Child Adolesc Psychiatry. 2003; 42(2):209-16. DOI: 10.1097/00004583-200302000-00015. View

18.

Quintana H, Birmaher B, Stedge D, Lennon S, Freed J, Bridge J . Use of methylphenidate in the treatment of children with autistic disorder. J Autism Dev Disord. 1995; 25(3):283-94. DOI: 10.1007/BF02179289. View

19.

Handen B, Feldman H, Gosling A, Breaux A, McAuliffe S . Adverse side effects of methylphenidate among mentally retarded children with ADHD. J Am Acad Child Adolesc Psychiatry. 1991; 30(2):241-5. DOI: 10.1097/00004583-199103000-00012. View

20.

Jensen V, Larrieu J, Mack K . Differential diagnosis between attention-deficit/hyperactivity disorder and pervasive developmental disorder--not otherwise specified. Clin Pediatr (Phila). 1997; 36(10):555-61. DOI: 10.1177/000992289703601001. View